altimmune glp-1 Readout Newsletter: Altimmune, Eli Lilly, CDC, FDA, Boston Altimmune Relocating Headquarters from Maryland

Nurse practitioner Tim Nicaise tried everything to lose weight without success

Download our new white paper to learn more: #wearemedimpact #atruepartner #GLP1s #healthcare #research MedImpact Healthcare Systems, Inc.

El uso de medicamentos GLP-1 como semaglutida para bajar de peso se ha duplicado en la ltima dcada, pero su uso ha disminuido entre los diabticos tipo 2, segn un nuevo estudio.

Supports Hormonal Weight Management: Specifically addresses the unique weight loss hurdles created by shifting hormones, making it easier for women over 40 to see real, lasting results

$58B GLP-1 Weight Loss Showdown The GLP-1 market is turning into a high-stakes battle between two pharmaceutical giants: Novo Nordisk Wegovy & Ozempic Eli Lilly Zepbound & Mounjaro Key points: Explosive growth:Already exceeding $58 billion in market size and accelerating rapidly

We will continue to monitor the phenomenal up-take of GLP-1 drugs (recognizing its growing pipeline shown in the chart above) and patients perspectives of the use of these medications both those people prescribed them to treat medical obesity and those consumers willing to pay for them out-of-pocket